Dr. Kathryn Moore received her Ph.D. from McGill University in Montreal, Canada, for her research on host-pathogen interactions. Although this early research focused on the immune response to infectious agents, Dr. Moore became fascinated with the mechanisms of “sterile” inflammation in disease, and moved to Boston to pursue postdoctoral training at Harvard Medical School, focusing on the mechanisms of chronic inflammation in lupus and atherosclerosis. She joined the faculty at Harvard Medical School and Massachusetts General Hospital as an Assistant Professor in 2001, where she remained until her move to NYU School of Medicine in 2009.
Dr. Moore is currently a Professor in the Departments of Medicine and Cell Biology, and a member of the Marc and Ruti Bell Vascular Biology and Disease Program. Dr. Moore has made seminal contributions to our understanding of the pathways that promote atherosclerosis, in such varied areas as innate immunity, immune cell trafficking, and microRNA regulation of cholesterol metabolism. In recognition of these contributions, she has been the recipient of several prestigious awards, including the Ellison Foundation New Scholar in Aging Award, the American Heart Association’s Special Recognition Award in Vascular Biology and the Jeffrey M. Hoeg Arteriosclerosis Award for Basic Science and Clinical Research.
« Go Back